Bio Immunitas

+44 (0)20 7692 8489 info@bioimmunitas.com

PUBLICATIONS

  1. Haq M., Haq S., Tutt P., and Crook M. Plasma sialic acid in myocardial infarction. Biochem. Soc. Trans. 20:343, 1992.
 
  1. Haq M., Haq S., Tutt P., and Crook M. Serum total sialic acid and lipid associated sialic acid in normal subjects and those having a myocardial infarction and their relation to acute phase proteins. Ann. Clin. Biochem. 30: 383-386, 1993.
 
  1. Haq S., Haq M., Tutt P., and Crook M. Serum sialic acid and acute phase proteins in hypertriglyceridaemic patients showing the Frederickson’s type IIB phenotype. Clin. Science. 85: 219-222, 1993.
 
  1. Crook M., Haq S., Haq M., and Tutt P. The relationship of serum total sialic acid with serum acute phase proteins and lipoprotein (a) in patients with severe hypertriglyceridaemia. Eur. J. Clin. Invest. 24: 179-181,1994.
 
  1. Crook M., Haq S., Chusney G., Haq M., and Tutt P. Acute phase proteins and lipoprotein (a) in patients with severe hypercholesterolaemia and normal subjects. Clin. Chim. Acta. 224: 199-201, 1994.
 
  1. Crook M., Haq M., Haq S., and Tutt P. Serum sialic acid and acute phase proteins in patients with myocardial infarction. Angiology. 45: 709-715, 1994.
 
  1. Crook M., Haq M., Haq S., and Tutt P. Serum lipids, acute phase proteins and serum cholinesterase in normal subjects. Scand. J. Clin. Lab. Med. 54: 601-605, 1994.
 
  1. Watts G. F., Crook M. A., Haq S., and Mandalia S. Serum sialic acid as an indicator of change in coronary artery disease. Metabolism. 44, No.2: 147-149, 1995.
 
  1. Crook M., Haq M., Haq S., and Tutt P. The relationship between serum total sialic acid and various haematological indices. Clin. Science. 94: 122-125. 1997.
 
  1. Haq S.E., Clerk A. and Sugden P. Activation of the mitogen-activated protein kinases (SAPK/JNKs, p38 MAPKs and ERKs) in the adenosine perfused rat heart. FEBS Lett. Sep 4, 434(3): 305-308, 1998.
 
  1. Choukroun G., Hajjar R., Fry S., del Monte F., Haq S., Guerrero J.L., Picard M., Rosenzweig A., Force T. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases. J. Clin. Invest. 104: 391-398, 1999.
 
  1. De Windt L.J., Lim H.W., Haq S., Force T., Molkentin J.D. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 5;275(18):13571-9. 2000.
 
  1. Haq S., Choukroun G., Kang Z.B., Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T. Glycogen synthase kinase-3 is a negative regulator of cardiomyocyte hypertrophy. J. Cell Biol. 151:117-129, 2000.
 
  1. Haq S., Choukroun G., Lim H., Tymitz K.M., del Monte F., Gwathmey J., Grazette L., Michael A., Hajjar R.J., Force T, Molkentin JD. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced failure. Circulation. 103:670-677, 2001.
 
  1. Force T., Haq S., Kilter H., Michael A. Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway regulates cardiomyocyte hypertrophy. Circulation. Jan 29;105 (4): 402-4. 2002.
 
  1. Force T., Michael A., Kilter H., Haq S. Stretch-activated pathways and left ventricular remodeling. J. Card. Fail. Dec;8(6 Suppl): S351-8. Review. 2002.
 
  1. Haq S., Michael A., Andreucci M., Bhattacharya K., Dotto P., Walters B., Woodgett J., Kilter H., Force T. Stabilization of -catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc. Natl. Acad. Sci. U S A. Apr 15;100 (8): 4610-5. 2003.
 
  1. Haq S., Kilter H., Michael A., Tao J., O’Leary E., Sun X.M., Walters B., Bhattacharya K., Chen X., Cui L., Andreucci M., Rosenzweig A., Guerrero J.L., Patten R., Liao R., Molkentin J., Picard M., Bonventre J.V., Force T. Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Medicine. Jul;9(7): 944-51 2003.
 
  1. Haq S., Kilter H., Michael A., Tao J., O’Leary E., Sun X.M., Walters B., Bhattacharya K., Chen X., Cui L., Andreucci M., Rosenzweig A., Guerrero J.L., Patten R., Liao R., Molkentin J., Picard 22. M., Bonventre J.V., Force T. Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Erratum in: Nat Medicine. Sep;9(9):1221. 2003.
 
  1. Andreucci M., Michael A., Kramers C., Park K.M., Chen A., Matthaeus T., Alessandrini A., Haq S., Force T., Bonventre J.V. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int. Oct;64(4):1189-98. 2003.
 
  1. Michael A., Haq S., Chen X., Cui L., Walters B., Bhattacharya K., Andreucci M., Guerrero J.L., Patten R., Liao R., Molkentin J., Force T. Profound abnormalities in cardiac growth, systolic and diastolic function, and calcium homeostasis in a transgenic mouse over-expressing glycogen synthase kinase-3b. J. Biol. Chem. May 14;279(20):21383-93. 2004.
 
  1. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., Michael A., Haq S., Nuedling S., Grohe C., Force T., Mendelsohn M.E., Karas R.H. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res. Oct 1;95(7):692-9. 2004.
 
  1. Chen X., Shevtsov S.P., Hsich E., Cui L., Haq S., Aronovitz M., Kerkela R., Molkentin J.D., Liao R., Salomon R.N., Patten R., Force T. The beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Cell Biol. Jun;26(12):4462-73. 2006.
 
  1. Shevtsov S., Haq S., Force T. Activation of beta-catenin signaling pathways by classical G-protein-coupled receptors: mechanisms and consequences in cycling and non-cycling cells. Cell Cycle. Oct;5(20):2295-300. 2006.
 
  1. Haq S. Critical Molecular Switch. Body Language. 34:37-42. 2009.
 
  1. Haq S. Critical Molecular Switch – b-Catenin’s pathway to anti-ageing? European Journal of Medical Aesthetics and Ageing. 3;15-18. 2010.
 
  1. Haq M. and Haq S. The Male Andropause and Ageing. Body Language 37: 39-40. 2010.
 
  1. Haq S. Pathogenesis of Obesity. Body Language. 38:33-38. 2010.
 
  1. Haq S., Storck R., Baspeyras M., Thio A., Campion C., Essayagh E., Jane R., and Fontdevilla Font J. A Multi-national, Multi-country, Multi-patient Study of Calcium Hydroxylapatite (Radiesse™ dermal filler) for Treatment of the Hand, European Dermatologic Consortium on Hand Augmentation. Dermatological Surgery. 2010.
 
  1. Haq M. and Haq S. Topical and Systemic Antioxidants. Body Language. 2013.
 
  1. Quillinan NP, McIntosh D, Haq S and Denton CP. Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (Aimspro®): a phase II double-blind placebo-controlled trial. Ann. Rheu. Diseases. 2014 Jan;73(1):56-61.
 
  1. Quillinan N, Clark KE, Youl B, Vernes J, McIntosh D, Haq S, Denton CP. Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis. Arthritis Res Ther. 2017 Mar 7;19(1):45.
 
  1. Onset and Duration of AbobotulinumtoxinA for Aesthetic Use in the Upper face: A Systematic Literature Review. Mark Nestor, MD, PhD, Joel L. Cohen, MD, Marina Landau, MD, Said Hilton, MD, Andreas Nikolis, MD, Syed Haq, MBBS, PhD, Maurizio Viel, MD, Bill Andriopoulos, PhD, Inna Prygova, MD, Keith Foster, PhD, Alessio Redaelli, MD, and Philippe Picaut, PharmD, PhD. J Clin Aesthet Dermatol. 2020 Dec; 13(12): E56–E83. 2020